Zinforo receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
05:53 EDT 22 Jun 2012 | European Pharmaceutical Review
Zinforo receives positive CHMP opinion...
Original Article: Zinforo receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
More From BioPortfolio on "Zinforo receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
